We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

IRhythm Technologies Inc (IRTC) USD0.001

Sell:$102.85 Buy:$102.88 Change: $2.35 (2.23%)
Market closed |  Prices as at close on 21 June 2024 | Switch to live prices |
Change: $2.35 (2.23%)
Market closed |  Prices as at close on 21 June 2024 | Switch to live prices |
Change: $2.35 (2.23%)
Market closed |  Prices as at close on 21 June 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.

Contact details

699 8th Street, Suite 600
United States
+1 (415) 6325700

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$3.20 billion
Shares in issue:
31.10 million
Health Care Equipment
United States
US dollar
NASDAQ Comb. Composite

Key personnel

  • Quentin Blackford
    President, Chief Executive Officer, Director
  • Brice Bobzien
    Chief Financial Officer
  • Minang Turakhia
    Executive Vice President, Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
  • Sumi Shrishrimal
    Executive Vice President, Chief Risk Officer
  • Daniel Wilson
    Executive Vice President - Corporate Development, Investor Relations
  • Mervin Smith
    Executive Vice President - Business Operations
  • Patrick Murphy
    Chief Business Officer, Chief Legal Officer
  • Chad Patterson
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.